ATTENDEES
The following delegates have already registered to attend OIS@ASRS. Sign up today to be added to this growing list!
A
AccelLAB
Francois Bergeron, MSc, Director Business Development
Alimera Sciences
Antonio Cutino, VP, Medical Affairs
Rick Eiswirth, President & CEO
Samer Kaba, Chief Medical Officer
Acucela
John Shishilla, SVP, Retinal Health Monitoring
Adverum Biotechnologies
Sandipan Bagchi, Executive Director, Business Development
Mehdi Gasmi, President & Chief Scientific Officer
Claire Gelfman, VP, Pharmaceutical Development
Carol Hoang-Roller, VP, Medical Affairs
Adam Turpcu, Director, Clinical Sciences
Jason Wang, Senior Manager, Corporate Strategy & Investor Relations
Aerie Pharmaceuticals
Vince Anido, PhD, Chairman & CEO
Ami Bavishi, Investor Relations
Eric Carlson, VP, Head, R&D
Gianluca Corbinelli, Chief Commercial Officer, Europe
Tad Heitmann, MBA, Director, Corporate Communications
Casey Kopczynski, PhD, Chief Scientific Officer
Cheng-Wen Lin, Director, Drug Delivery & Pharmacology
Mike McCleerey, VP, Portfolio Development
AffaMed Therapeutics
MaryJane Rafii, PhD, MBA, Senior Vice President
Alcon
Ravi Durvasula, PhD, Retinal Surgical Instrumentation R&D
Wesley Elden, Global Product Director, Surgical Retina
Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Patrick Matthews, Head, BD&L Transactions
Patrick Sadd, Global Director, CAT Marketing
Matthew Snakenberg, Head, Global BD&L and M&A
Jay Stark, Global Head, Surgical Visualization
Alkahest
Elizabeth Jeffords, Chief Commercial & Strategy Officer
Erin Newman, VP, Program Development
Esther Rawner, MD, Medical Director
All Eyes Consulting
Namrata Saroj, OD, Director
Allegro Ophthalmics
Scott Cooper, CFO
Hampar Karageozian, Executive Chairman
Vicken Karageozian, MD, President & CEO
John Park, PhD, Chief Scientific Officer & VP, Mfg Development
Allergan
Doug Faunce, PhD, Executive Director, External Science & Innovation
Jai Parekh, MD, MBA, FAAO, Chief Medical Officer & VP
Chuck Silberstein, MD, Senior Vice President
Alpine Biotherapeutics
Keith Bryant, Business Adviser
Aptitude Medical Systems
Scott Ferguson, CEO
Jackson Gong, COO
AsclepiX Therapeutics
Julia Balanova, Investor Relations
Josh Barer, Board of Directors
Niranjan Pandey, PhD, VP & Head, R&D
Wendy Perrow, MBA, CEO
Kevin Slawin, Board of Directors
Astellas Pharma
Tomoaki Yoshikawa, PhD, Manager, Senior Researcher
Austin Retina Associates
Robert Wong, MD, Physician
Avanti
Samir Tari, MD, MBA, Principal
Avella Specialty Pharmacy
Jim Rehovsky, Vice President
B
Bascom Palmer
Audina Berrocal, MD
Bausch + Lomb
Nathan Belcher, Design Engineering Manager
Mike Bradley, Product Manager, Surgical Retina
David Fisher, VP, Marketing
Chuck Hess, VP & General Manager, US Surgical
Val Kolesnitchenko, MD, Senior Director Medical Affairs
Brent Lindsey, National Sales Director
Kristy Marks, Director, Corporate Communications
Robert Niemietz, Senior Director, Marketing
Andrew Pilon, OD, Director, Ophthalmic Implants
Calvin Roberts, MD, SVP, Chief Medical Officer, Eye Health
Bausch Health
Evan Hua, Senior Business Development Analyst
Sandeep Lalit, VP, Business Development
Bayer
Daniel Janer, MD, Global Medical Affairs
Steven Jones
Belite Bio
Irene Wang, COO
Biovisics Medical
Jim Chiapetta, CEO
Blackstone Life Sciences
Emmett Cunningham, MD, PhD, MPH, Senior Managing Director
BridgeBio
Houman Hemmati, MD, PhD, Clinical Development
Barrett Katz, MD, President & Chief Medical Officer
Sandy Mong, MD, VP, Business Development & Operations
Glenn Noronha, Chief Scientific Officer
Bryn Mawr Communications
Janet Burk, Publisher
BTIG
Ryan Zimmerman, Director, Equity Research Medical Technology
C
C-Bridge Capital
Michael Keyoung, MD, PhD, Managing Director & Head, North America
California Retina Consultants
Robert Avery, MD, Founder
Canaan Partners
Wende Hutton, General Partner
Carl Zeiss Meditec
Andrew Chang, Head, Global Sales, Ophthalmic Devices
Robert Gibson, Senior Director, Product Management
Kevin Langton, Global Director, Professional Education Ophthalmic Diagnostics
Niranchana Manivannan, PhD, Senior Staff Scientist, Clinical Research & Analytics Development
Angelo Rago, Global Head, Ophthalmic Diagnostics
Carolina Retina Center
Jeffrey Gross, MD, Founder & President
Cativer Bio Insights
Stephen Judd, President
Cell Care Therapeutics
Shannon Dahl, PhD, Chief Scientific Officer
Nicholas Sohl, CEO
Charles Retina Institute
Steve Charles, MD, Founder & Chairman
Chengdu Kanghong Pharmaceutical Group
Li Liu, PhD, Associate Director, Corporate Development
Fang Zhang, Corporate Development Manager
ChiralLogicJoshua Parks, Founder
Clarion Healthcare
Carol Kearney, Managing Director
Clearside Biomedical
Thomas Ciulla, MD, Chief Medical Officer
Charlie Deignan, CFO
Rick McElheny, VP, Corporate Development
Coherus Biosciences
Rajat Agrawal, SVP, Clinical Development - Ophthalmology
Colorado Retina Associates, PC
Alan Kimura, MD
Compact Imaging
Don Bogue, CEO
D
Dalton & Associates
Michelle Dalton
Drusolv Therapeutics
John Edwards, CEO
Duke Eye Center
Michael Allingham, MD, PhD, Assistant Professor of Ophthalmology
Priyatham Mettu, MD, Assistant Professor of Ophthalmology
E
Eloxx Pharmaceuticals
Susan Schneider, MD, SVP, Clinical Development, Ophthalmology
Ethis
Etani Fajardo, EVP & General Manager
Luca M. Sergio, CEO & Owner
Michael Smolinsky, Chief Content Officer
Evolve Medical Education
Alan Guralnick, President
Evolve Therapeutics
Donald Fishbein, President
ExSight Ventures
Firas Rahhal, MD, Partner
Eyedaptic
Jay Cormier, CEO
EyeGate Pharma
Stephen From, CEO
EyePoint Pharmaceuticals
Tom Hadley, VP, Marketing & Sales
Scott Jones, Chief Commercial Officer
Dario Paggiarino, MD, Chief Medical Officer
Keyur Patel, VP, Medical Affairs
Josh Pettit, National Sales Manager
Michelle Poole, Senior Director, Marketing
Joe Smith, Executive Director, Business Development
Eyevensys
Patricia Zilliox, CEO & President
F
ForSight Labs
K. Angela Macfarlane, Managing Partner
Foundation Fighting Blindess
Chris Adams, VP Marketing
David Brint, Chairman of the Board
Michele DiVincenzo, Senior Director, Events & Chapters
Ben Shaberman, Senior Director, Scientific Outreach & Community Engagement
Jason Menzo, Chief Operating Officer
G
Genentech
Amitabha Bhakta, PhD, MSL
Christopher Brittain, MRCOphth, MD, MBA, Global Head, Ophthalmology, Clinical Development
Hao Chen, PhD, Lead Clinical Scientist
Ann Clark, Associate Director
Daniela Ferrara, MD, MSc, PhD, Medical Director, Ophthalmology
Jasmine Hsieh, Marketing Manager
Jason Lin, PharmD, Senior Marketing Manager
Jeanie Nguyen, Manager, Market Analysis & Strategy
Carlos Quezada-Ruiz, MD
Rachel Retajczyk, Marketing
Min Tsuboi, Principal MSL
Andrew Villani, Associate Director, Corporate Relations
Glauconix Biosciences
George Torrejon, Senior Director, Operations & Business Development
Gray Communications
Michele Gray, Principal
Graybug Vision
Fred Guerard, CEO
Charles Semba, MD, Chief Medical Officer
Jin-Zhong Zhang, PhD, VP, Preclinical Development
Gyroscope Therapeutics
Susan Hill, PhD, Chief Business Officer
H
Heidelberg Engineering
Kfir Azoulay, VP & Head, Corporate Strategy
Horizon Therapeutics
Todd Lewis, Senior Director, Commercial Development
I
Illinois Retina Associates
John Pollack, MD, Partner
InFocus Capital Partners
Ron Weiss, MD, Managing Partner
InFocus Clinical
Brad Doerschuk, President & CEO
Interface Biologics
Wendy Naimark, PhD, VP, R&D
Istanbul Bilim University
Murat Oncel, MD, Professor, Ophthalmology
J
Janssen R&D
Penny Fleck, Global Head, Strategy, CVMTA
Hamish Ross, PhD, Senior Director, Alliance Management
James Tobin, PhD, Vice President
jCyte
Paul Bresge, CEO
Johns Hopkins Technology Ventures
Amy House, Associate Director, Corporate Partnerships
K
Kala Pharmaceuticals
Kim Brazzell, MD, PhD, Chief Medical Officer
Niranjan Kameswaran, VP, Strategy
Steven Zhang, MD, PhD, VP, Medical Affairs
KKR
Arjun Arora, Principal
Kal Rao, Associate
Kodiak Sciences
Jason Ehrlich, MD, PhD, Chief Medical Officer & Chief Development Officer
Victor Perlroth, MD, Founder & CEO
L
Lexitas
Chad Ice, CEO
Michael Schiewe, Director, Business & Site Development
Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP
M
Market Scope
Peter Downs, Writer & Analyst
William Freeman, Vice President
Media MICE
Matt Young, CEO & Publisher
Miami Ocular Oncology & Retina (MOOR)
Timothy Murray, MD, MBA, FACS, Founding Director & CEO
N
National Alliance Eye Vision Research
James Jorkasky, Executive Director
NEA
Ali Behbahani, MD, General Partner
Needham
Serge Belanger, Analyst
Nevakar
Raul Trillo, Chief Commercial Officer
Edward Tykot, VP, Business Development
New England Eye Center
Jay Duker, MD, Director
New York Retina and Macula Institute
Aryeh Pollack, MD, CEO
Notal Vision
Grace Chang, MD, PhD, Chief Medical Officer
Kester Nahen, Chief Commercial Officer
Susan Orr, OD, CEO
Novartis
Raghava Evuru
O
OcuFLOW
Theresa Kramer, MD, MBA, Ophthalmic Pathologist
Ocugenix
Sean McDonald, President & CEO
Oculis
Riad Sherif, CEO
Oculos Clinical Research
Ronil Patel, Business Development
Ocunexus Therapeutics
Brian Levy, OD, MSc, CEO
Ocuphire Pharma
Mina Sooch, MBA, CEO
Ocutrx
Victoria McArtor, Chief Communications Officer
Ocutrx Vision Technologies
Michael Freeman, CEO & Chief Technology Officer
OD-OS GmbH
Winfried Teiwes, CEO & Managing Director
OIS Weekly
Rich Kirkner
Omar Consulting Group
Cheryl Rowe-Rendleman, PhD, CEO & Managing Consultant
ONL Therapeutics
David Esposito, CEO
Ophthalmology Times
Sheryl Stevenson, Group Editorial Director
Optceutics
Christopher Redhead, PhD, CEO
Opthea Limited
Megan Baldwin, PhD, Managing Director & CEO
Optos
Anne Marie Cairns, Chief Clinical Officer
Ora
Sanjeev Ganatra, Director, Business Development
Jeanne Hecht, Chief Strategy Officer
Lisa Jennings, Senior Director, Global Alliance Business Development
Richie Kahn, Director, Business Development
Josh Moriarty, Executive Director, Business Development
Aron Shapiro, SVP & Chief Commercial Officer
Stewart Sylvester, Business Development
Outlook Therapeutics
Terry Dagnon, COO
Jeff Evanson, Chief Commercial Officer
Jennifer Kissner, PhD, SVP, Clinical Development
OXURION NV
Andy De Deene, MD, Global Head, Development
Patrik De Haes, MD, CEO
Jean Feyen, PhD, Chief Scientific Officer
Gregoire Franoux, Head, Business Development & Licensing
Petra Kozma-Wiebe, MD, Director, Global Clinical Development
Wouter Piepers, Head, Corporate Communications & Investor Relations
P
Panoptes Pharma
Franz Obermayr, CEO
PanOptica
Paul Chaney, President & CEO
Martin Wax, MD, EVP, R&D & Chief Medical Offier
Patterson Thuente
Paul Onderick, OD, JD, Eye Doctor & Patent Attorney
PentaVision
Jennifer Ford, Senior Managing Editor, Retinal Physician & Glaucoma Physician Magazines
PharM&A Advisors
Philip Gioia, Managing Director
PhotoOpTx
Mike Judy, Board Member
Tom Kelly, CEO
Jeffrey Lenk, Chief Technology Officer
Piper Jaffray
Ryan Kaeding, Director
Mihir Mantri, Managing Director
Pivotal bioVenture Partners
Ash Khanna, PhD, Venture Partner
PolyActiva
Russell Tait, CEO
Powered Research
Chris Brasfield, Director, Business Development
Pr3vent
Jochen Kumm, Founder
Darius Moshfeghi, MD, Founder
Promedica International
Khan Lau, OD, MBA, Director, Clinical Operations
R
Regenera Pharma
Jordan Rubinson, CEO
Regeneron
Keith Baker, MD, Medical Director, Ophthalmology Medical Affairs
Abby Cahn, Director CBU Operational Effectiveness
Kevin Clark, Exeuctive Director Marketing
Emmanuel Hamon, Senior Director, Marketing - Diabetic Retinopathy
Vicky Jones
Darren Kwok, Associate Director Corporate Communications
John Magliocchetti, Senior Director, Marketing
Stephen Marshall, Strategic Analysis
David Scisciani, TLL
Michael Suesserman, VP, CBU Head, Ophthalmology
REGENXBIO
Paulo Falabella, MD, PhD, VP, Clinical Development
Rei Nakamura, PhD, Senior MSL
Steve Pakola, MD, SVP & Chief Medical Officer
Ram Palanki, SVP, Commercial Strategy & Operations
Sherri Van Everen, VP Clinical Development
Jesse Yoo, Senior Surgical Trainer
Retina Associates of Cleveland
Lawrence J. Singerman, MD, FACS, Founder
Retina Today
Michele Corry, Assistant Editor
Scott Krzywonos, Editor-in-Chief
Retina-Vitreous Associates Medical Group
David Boyer, MD
Retinal Consultants of Arizona
Pravin Dugel, MD, Managing Partner
Retinal Solutions
Scott Olson, CEO
Re-Vana Therapeutics
Michael Nash, Chief Commercial Officer
Michael O'Rourke, President & CEO
Review of Ophthalmology/Review of Optometry
Michele Barrett, Manager
Rimonci
Richel Liu, CEO
Roche Genentech
Yawen Chiang, PhD, Director, Product Optimization Lead
RTW Investments
Gotham Makker, Consultant, Strategic Investments
Steve Saland, Research Manager
Rush University
Pauline Merrill, MD, Section Director, Uveitis
S
Santen
Jean Kim, Venture Capital Analyst
SciFluor Life Sciences
Scott Edwards, PhD, VP & General Manger
Shire (A Takeda Company)
Susan Benton, Head, New Ophthalmic Products
Beth Marsh, Global Product Strategy Lead
SparingVision
Florence Allouche, PharmaD, CEO
Spark Therapeutics
Frank Nazzario, US Marketing Leader
Stargazer Pharmaceuticals
Gary Sternberg, MD, CEO
Stealth BioTherapeutics
Irene McCarthy, CEO
Brian Hotchkiss, Head, Business Development & New Product Planning
Syneos Health
Nicholas Spittal, SVP, Clinical Development
T
Takeda Pharmaceutical
Kim Paes, Clinical Development Scientist
Texere Publishing
Neil Hanley, Publisher
TFG Education
Brad Fundingsland, President
Rebecca Winter, Global Business Development
TGP Communications
Teresa Panas, Principal
Torreya
Anna Makki, Managing Director
Tracery Ophthalmics
Chris Bott, Senior Adviser
Shelley Boyd, MD, President & CEO
Trial Runners
Brandon Beaudoin, Director, Clinical Development
Patrick Healy, MPH, Co-Founder, Executive Chairman
Cameron Marshall, Business Development Director
U
University Hospital Bern
Marion Munk, MD, PhD
University of California, Davis
Glenn Yiu, MD, PhD, Associate Professor
University of California, Irvine
Baruch Kuppermann, MD, PhD, Steinert Professor and Chair, Department of Ophthalmology, Gavin Herbert Eye Institute
University of Pittsburgh School of Medicine
José Sahel, MD, Chair, Department of Ophthalmology and The Eye & Ear Foundation Endowed Chair
University of Southern California
Mark Humayun, MD, PhD, Professor, Ophthalmology
UPMC Enterprises
Alexander Anetakis, MD, Physician Advisor
USC Keck School of Medicine, USC Eye Institute
Linda Lam, MD, MBA
V
Valley Retina Institute
Victor Gonzalez, MD, CEO
Verana Health
Bill Abbott, Business Development Executive - Clinical Trials
Chet Kumar, VP, Life Science & Commercial
Vestrum Health
Nadeem Ahmad, COO
Visant Medical
Vartan Ghazarossian, President & CEO
Vision Ophthalmic Development International
Rhett Schiffman, MD, MS, MHSA, President & CEO
Visionary Venture Fund
Garett Hamontree, Principle
VisionCare
Blake Michaels, President & CEO
Vitreous Retina Macula Specialists of Toronto
Netan Choudhry, MD, Founder & Medical Director
W
Warrenville EyeCare & LASIK
Lisa Nijm, MD, JD, Founder & Medical Director
Wave Life Sciences
Michael Byrne, PhD, Director in Vivo Biology & Ophthalmology
Weill Cornell Medicine
Szilard Kiss, MD, Director, Clinical Research & Chief, Retina Service
Windsor Laser Eye Institute, Kresge Eye Institute
Pradeepa Yoganathan, MD, Assistant Professor
#
21GRAMS
Justin LaMonica, VP, Strategy
2CTech
James Taylor, CEO
Stacy Evans, MD